Berberine and Cisplatin Exhibit Synergistic Anticancer Effects on Osteosarcoma MG-63 Cells by Inhibiting the MAPK Pathway

Berberine (BBR) has been reported to have potent anticancer activity and can increase the anticancer effects of chemotherapy drugs. The present study aims to investigate whether BBR and cisplatin (DDP) exert synergistic effects on the osteosarcoma (OS) MG-63 cell line. In the present study, MG-63 ce...

Descripción completa

Detalles Bibliográficos
Autores principales: Gao, Xianxian, Zhang, Chen, Wang, Yanjie, Zhang, Ping, Zhang, Jingyu, Hong, Tie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8002572/
https://www.ncbi.nlm.nih.gov/pubmed/33802664
http://dx.doi.org/10.3390/molecules26061666

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8002572/
https://www.ncbi.nlm.nih.gov/pubmed/33802664
http://dx.doi.org/10.3390/molecules26061666

Ejemplares similares